described a subtype of adenosine receptor CD39+Tregs that was decreased in patients with ITP, but after HD-DXM therapy, the responding patients showed an increase in Tregs and their ability to immunosuppress was improved (33). Here, ENTPD1 is linked to autoimmune thrombocytopenic purpura.